On December 3, 2010, the Finnish Funding Agency for Technology and Innovation (TEKES) awards funding for Neurotar’s R&D project. The Finnish Funding Agency for Technology and Innovation announced its decision to fund the first phase of Neurotar’s Research & Development project aimed at developing Neurotar’s services in the areas of CNS and dermatology. The title […] Read more »
Neurotar has upgraded its production capabilities by adding a state-of-the-art two-photon microscope optimized for in vivo imaging tests (by Olympus Europe). Thanks to the Olympus staff for their flexibility and professional support!
Our more than thirty meetings with prospective Clients and Partners showed that currently there is a particularly strong interest in our skin-related services. This realization motivates us to reconsider our priorities and to plan for such improvements and adjustments to our equipment that make it more suitable for experiments on skin of human subjects.
After approximately half-year long discussions with our long-time friends, foreign private investors, we have received their first round of financing. We are lucky to enjoy a high trust relationship with our investors, who show keen interest in Neurotar’s international growth.
The project is intended to finance the development of three initial service products, and there is an understanding with TEKES that, if successful, “Beyond the Surface. Phase One” will be followed by a second project, encompassing two additional service products.